FT Health: Combating Cancer

Have blunt instrument drugs like chemotherapy had their day? Plus: genetic research makes personalised treatments a reality, the push to immunotherapy, apps that extend lives, the scourge of western lifestyles and the ‘toxicity’ of cancer drugs’ cost

© AFP

Patients with an adverse prognosis may benefit particularly from new genomic approach to disease

High prices subject some patients to long-term collateral damage to incomes and health

Obesity poised to overtake smoking as leading risk factor, warn researchers

Genetic research advances are making truly personalised treatments a reality

Combining established drugs with experimental medicines has raised survival rates

System forewarns doctors when sufferer’s symptoms deteriorate